Gil Awada - Dissemin

All papers authored by Gil Awada

This paper is made freely available by the publisher.

2024 Gil Awada

, Julia Katharina Schwarze, Jens Tijtgat, Giuseppe Fasolino, Mark Kockx, Bart Neyns

Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF^V600/NRAS^Q61 Wild-Type Melanoma (TraMel-WT)

Download from doi.org

2023 Giuseppe Fasolino, Gil Awada

, Laura Moschetta

, Jorgos Socrates Koulalis, Bart Neyns

, Bert Verhelst, Peter Van Elderen, Pieter Nelis, Paul Cardon de Lichtbuer, Wilfried Cools

, Marcellinus Ten Tusscher

Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study

Download from doi.org

2022 Julia Katharina Schwarze

, Jens Tijtgat, Gil Awada

, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns

Intratumoral administration of CD1c (BDCA-1)⁺and CD141 (BDCA-3)⁺myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Y. Jansen

, A. A. M. van der Veldt

, G. Awada

, B. Neyns

Anti-PD-1: When to Stop Treatment

Upload

Julia Katharina Schwarze

, Soizic Garaud, Yanina J. L. Jansen, Gil Awada

, Valérie Vandersleyen, Jens Tijtgat

, Alexandre de Wind, Paulus Kristanto, Teofila Seremet, Karen Willard-Gallo

, Bart Neyns

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial

Download from doi.org

2021 Johnny Duerinck, Julia Katharina Schwarze

, Gil Awada

, Jens Tijtgat, Freya Vaeyens, Cleo Bertels, Wietse Geens

, Samuel Klein, Laura Seynaeve, Louise Cras, Nicky D’Haene, Alex Michotte, Ben Caljon, Isabelle Salmon, Michaël Bruneau and 6 other authors

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

Download from doi.org

Sim Vermeulen, Gil Awada

, Marleen Keyaerts

, Bart Neyns

, Hendrik Everaert

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome

Download from doi.org

Gil Awada

, Julia Katharina Schwarze

, Jens Tijtgat

, Giuseppe Fasolino, Hendrik Everaert, Bart Neyns

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)

Download from doi.org

Yanina J. L. Jansen

, Inneke Willekens, Teofila Seremet, Gil Awada

, Julia Katharina Schwarze

, Johan De Mey, Carola Brussaard, Bart Neyns

Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse

Download from doi.org

Gil Awada

, Yanina Jansen

, Julia Katharina Schwarze

, Jens Tijtgat

, Lennert Hellinckx, Odrade Gondry, Sim Vermeulen, Sarah Warren, Kelly Schats, Pieter-Jan van Dam

, Mark Kockx, Marleen Keyaerts

, Hendrik Everaert, Teofila Seremet

, Anne Rogiers

and 1 other authors

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

Download from doi.org

2020 Julia Katharina Schwarze

, Gil Awada

, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts

, Ivan Van Riet

, Bart Neyns

Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial

Download from doi.org

Gil Awada

, Laila Ben Salama, Jennifer De Cremer, Julia Katharina Schwarze, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, Anne Rogiers

, Peter Theuns, Johnny Duerinck, Bart Neyns

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Gil Awada